These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9147410)

  • 1. The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review.
    Bernstein HG; Kirschke H; Wiederanders B; Pollak KH; Zipress A; Rinne A
    Mol Chem Neuropathol; 1996 Apr; 27(3):225-47. PubMed ID: 9147410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
    Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
    J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged.
    Ii K; Ito H; Kominami E; Hirano A
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(3):185-94. PubMed ID: 8236812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome.
    Gyure KA; Durham R; Stewart WF; Smialek JE; Troncoso JC
    Arch Pathol Lab Med; 2001 Apr; 125(4):489-92. PubMed ID: 11260621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease: genotypes, phenotypes, and treatments.
    Selkoe DJ
    Science; 1997 Jan; 275(5300):630-1. PubMed ID: 9019820
    [No Abstract]   [Full Text] [Related]  

  • 6. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease.
    Cataldo AM; Paskevich PA; Kominami E; Nixon RA
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):10998-1002. PubMed ID: 1837142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.
    Barone E; Head E; Butterfield DA; Perluigi M
    Free Radic Biol Med; 2017 Oct; 111():262-269. PubMed ID: 27838436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
    Takahashi RH; Nagao T; Gouras GK
    Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal loss and beta-amyloid removal in the amygdala of people with Down syndrome.
    Weģiel J; Wísniewski HM; Moryś J; Tarnawski M; Kuchna I; Dziewiatkowski J; Pirttilä T; Krivimäki T; Lehtimäki T; Lach B
    Neurobiol Aging; 1999; 20(3):259-69. PubMed ID: 10588573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E genotype in senile dementia with tangles differs from Alzheimer's disease.
    Tolnay M; Villoz N; Probst A; Miserez AR
    Neuropathol Appl Neurobiol; 2003 Feb; 29(1):80-4. PubMed ID: 12581343
    [No Abstract]   [Full Text] [Related]  

  • 17. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
    Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients.
    Levy E; Sastre M; Kumar A; Gallo G; Piccardo P; Ghetti B; Tagliavini F
    J Neuropathol Exp Neurol; 2001 Jan; 60(1):94-104. PubMed ID: 11202179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain.
    Ingelsson M; Fukumoto H; Newell KL; Growdon JH; Hedley-Whyte ET; Frosch MP; Albert MS; Hyman BT; Irizarry MC
    Neurology; 2004 Mar; 62(6):925-31. PubMed ID: 15037694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.